Skip to main content
Funded Studies

Raymond Joseph Tesi, MD

CEO, President and acting Chief Medical Officer at INmune Bio

Location: Scranton, PA United States

Raymond J. Tesi, MD, has been President, Chief Executive Officer, and acting Chief Medical Officer of INmune Bio since its founding in September 2015. From 2011 to 2015, Dr. Tesi was CEO, President, and Acting Chief Medical Officer of FPRT Bio Inc., a development-stage biotech company formed to develop XPro1595 for the treatment of neurodegenerative and other inflammatory diseases. During his time in the biotechnology industry, he has focused on the development of therapies that interface with the complex biology of inflammation and immunology. Prior to joining the field in 1997, he spent a decade as an academic transplant surgeon with expertise in liver, pancreas, and kidney transplantation. Dr. Tesi received his medical degree from Washington University School of Medicine (and will challenge anyone to a game of tennis as long as it is on clay)!

Associated Grants

  • Therapeutic Effects of XPro1595 on Motor and Non-motor Outcomes in a Pre-clinical Model of Parkinson's disease


  • Peripheral Administration of XPro1595 in the Pre-clinical 6-OHDA Model of Parkinson's Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.